BİLİCİ, A. Et Al. 2022. Pazopanib in metastatic soft tissue sarcoma (STS): Results of a multi-institutional observational study.. American Society of Clinical Oncology (ASCO) 2022 Annual Meeting , (United States Of America).

BİLİCİ, A., KOCA, S., KARAAĞAÇ, M., ERASLAN, E., OCAK, B., GÖKTAŞ AYDIN, S., ... SEZGİN GÖKSU, S.(2022). Pazopanib in metastatic soft tissue sarcoma (STS): Results of a multi-institutional observational study. . American Society of Clinical Oncology (ASCO) 2022 Annual Meeting, United States Of America

BİLİCİ, AHMET Et Al. "Pazopanib in metastatic soft tissue sarcoma (STS): Results of a multi-institutional observational study.," American Society of Clinical Oncology (ASCO) 2022 Annual Meeting, United States Of America, 2022

BİLİCİ, AHMET Et Al. "Pazopanib in metastatic soft tissue sarcoma (STS): Results of a multi-institutional observational study.." American Society of Clinical Oncology (ASCO) 2022 Annual Meeting , United States Of America, 2022

BİLİCİ, A. Et Al. (2022) . "Pazopanib in metastatic soft tissue sarcoma (STS): Results of a multi-institutional observational study.." American Society of Clinical Oncology (ASCO) 2022 Annual Meeting , United States Of America.

@conferencepaper{conferencepaper, author={AHMET BİLİCİ Et Al. }, title={Pazopanib in metastatic soft tissue sarcoma (STS): Results of a multi-institutional observational study.}, congress name={American Society of Clinical Oncology (ASCO) 2022 Annual Meeting}, city={}, country={United States Of America}, year={2022}}